Epilepsy is one of the most common neurological diseases. It is caused by a malfunction in brain cells and is usually treated with medicines that control or counteract the seizures.
Scientists from the...
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six...
Lower back pain can be divided into categories – non-specific and specific. The former is the far more common type of back pain, according to Bupa. It describes back pain that cannot be easily attributed...
A consortium of 17 U.S. cancer centers – including Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine – have come together to better understand the consequences...
The number of people with type 2 diabetes is expected to exceed the five million mark by 2030. The number of people that officially have diabetes is estimated to be one million off the actual figure. Both...
In an aging society, one of the most important and urgent tasks of scientific research is to counteract the decline in motor function and muscle weakness that accompanies the aging process.
A research...
A new type of immunotherapy for the skin cancer malignant melanoma shows promising results. Three severely ill patients are now long-term survivors. The study, published in OncoImmunology, is the result...
The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday.
The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified...
High blood pressure can seem lower down on your list of health priorities because it does not produce any symptoms. It is therefore tempting to downplay its significance. Such complacency could be life-threatening,...
In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease. It was previously believed that these mutations acted in concert in...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok